162 related articles for article (PubMed ID: 3830266)
1. HLA antigens in multiple sclerosis in Alsace.
Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
[TBL] [Abstract][Full Text] [Related]
2. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
[TBL] [Abstract][Full Text] [Related]
3. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
[TBL] [Abstract][Full Text] [Related]
4. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
Madigand M; Fauchet R; Oger J; Sabouraud O
Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
[TBL] [Abstract][Full Text] [Related]
5. HLA antigen segregation analysis in multiple sclerosis (MS) families.
Bertrams J; Kuwert E
Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375
[TBL] [Abstract][Full Text] [Related]
6. HLA associations with multiple sclerosis in Sicily and Malta.
Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
[TBL] [Abstract][Full Text] [Related]
7. [Multiple sclerosis and the histocompatibility system].
Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
[TBL] [Abstract][Full Text] [Related]
8. HLA and Japanese MS.
Naito S; Kuroiwa Y; Itoyama T; Tsubaki T; Horikawa A; Sasazuki T; Noguchi S; Ohtsuki S; Tokuomi H; Miyatake T; Takahata N; Kawanami S
Tissue Antigens; 1978 Jul; 12(1):19-24. PubMed ID: 80838
[TBL] [Abstract][Full Text] [Related]
9. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
10. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
Bertrams HJ; Kuwert EK
J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: HLA studies in Italy.
Conighi C
Ital J Neurol Sci; 1987 Jun; Suppl 6():41-3. PubMed ID: 3498705
[No Abstract] [Full Text] [Related]
12. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
Fdez-Morera JL; Tunon A; Rodriguez-Rodero S; Rodrigo L; Martinez-Borra J; Gonzalez S; Lopez-Vazquez A; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2006 May; 67(5):409-14. PubMed ID: 16671949
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis in 3 gipsy and 2 partly gipsy subjects (a clinical and immunogenetic study).
Pálffy G; Gyódi E; Petrányi G
Acta Med Hung; 1986; 43(1):31-7. PubMed ID: 3774417
[TBL] [Abstract][Full Text] [Related]
14. [HLA and familial multiple sclerosis].
Barroche G; Perrier P; Raffoux C; Gehin P; Streiff F; Weber M
Rev Neurol (Paris); 1986; 142(10):738-45. PubMed ID: 3823705
[TBL] [Abstract][Full Text] [Related]
15. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
16. Studies of HLA antigens in multiple sclerosis.
Jersild C
Boll Ist Sieroter Milan; 1978 Jan; 56(6):516-30. PubMed ID: 415750
[TBL] [Abstract][Full Text] [Related]
17. [Histocompatibility antigens in multiple sclerosis patients].
Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
[TBL] [Abstract][Full Text] [Related]
18. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR-dependent variation of intrathecal IgG1 (Gm) allotype synthesis in multiple sclerosis.
Salier JP; Martin-Mondiere C; Sesboüé R; Daveau M; Goust JM; Govaerts A; Schuller E; Degos JD
J Immunol; 1985 Mar; 134(3):1551-4. PubMed ID: 3855432
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis].
Shiralieva RK; Guseĭnova KA
Klin Med (Mosk); 1998; 76(1):19-20. PubMed ID: 9532908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
